|
|
||||||||
B activation pathways induced by T cell costimulation

* University of Bern, Department of Chemistry and Biochemistry, CH-3012 Bern, Switzerland; and
Immunobiology Program, Department of Medicine, University of Vermont, Burlington, Vermont, USA
1Correspondence: University of Bern, Department of Chemistry and Biochemistry, Freiestr. 3, CH-3012 Bern, Switzerland. E-mail: Lienhard.Schmitz{at}ibc.unibe.ch
| ABSTRACT |
|---|
|
|
|---|
B activation pathway while biochemical approaches started to unveil their functional mechanisms. These results show that NF-
B activation depends on an early wave of tyrosine phosphorylation that allows the inducible formation of multiprotein complexes containing several proteins required for NF-
B activation: adaptor proteins including Src homology 2 domain-containing leukocyte phosphoprotein 76 (SLP-76) and proteins with enzymatic activity, such as phospholipase C (PLC)
and the exchange factor Vav1. While Vav1 contributes to Rac-dependent reorganization of the actin cytoskeleton, activated PLC
1 generates the protein kinase C (PKC) activator diacylglycerol. In T cells, the novel PKC isoform PKC
is indispensable for NF-
B activation and its enzymatic activity depends on recruitment to the immunological synapse. Downstream from PKC
, the caspase recruitment domain (CARD) proteins CARD11/CARMA1 and Bcl10 relay T cell receptor-derived signals to the I
B kinase (IKK) complex. Many members of the NF-
B activation cascade, including the IKKs, are either constitutively or inducibly translocated to the lipid raft fraction, showing a highly organized spatial distribution of these NF-
B activating proteins.Schmitz, M. L., Bacher, S., Dienz, O. NF-
B activation pathways induced by T cell costimulation.
Key Words: IKK Vav PKC
| INTRODUCTION |
|---|
|
|
|---|
B/Rel family are important for the maturation and survival of T lymphocytes and the induced expression of gene products mediating innate and adaptive immunity. Although the NF-
B activation pathways induced by IL-1 and TNF
are relatively well characterized, the components of the NF-
B activation cascade triggered by T cell costimulation are just emerging. T lymphocytes become fully activated by an antigen-presenting cell (APC) through triggering of their T cell receptor (TCR) complex and a costimulatory receptor such as CD28. T cell activation depends on simultaneous delivery of signals from both receptors, as repeated stimulation of the TCR alone leads to anergy and activation-induced cell death (1)
|
At a biochemical level, the principle of costimulation is mirrored by the activation of NF-
B (2)
. NF-
B target genes mediate innate and adaptive immune responses and contribute to the control of cell proliferation and apoptosis. The contribution of NF-
B to innate immunity is mediated through induction of genes encoding cytokines, chemokines, enzymes, and antimicrobial peptides, making this transcription factor indispensable for building the first line of defense against invading pathogens (3)
. A variety of functions contribute to the role of NF-
B in adaptive immunity, including its antiapoptotic effects and the induced expression of MHC proteins, costimulatory molecules such as B7.1, and cytokines including IL-2, IL-12, and IFN
(4)
.
The NF-
B transcription factor system consists of various DNA binding dimers that are retained in the cytoplasm upon association with an inhibitory I
B protein. For a detailed description, consult some recent, excellent reviews (5
, 6)
. Activation of NF-
B by a wide array of stimuliincluding cytokines such as IL-1 and TNF
, byproducts of bacterial and viral infections, radiation, or T cell costimulationleads to the onset of signaling cascades that ultimately converge at the level of the IKK complex. This complex is composed of the two catalytic subunits IKK
and IKKß and the regulatory IKK
(NEMO, IKKAP) protein. The IKK complex inducibly phosphorylates I
B proteins, including I
B
, I
Bß, and I
B
. Phosphorylated I
B is recognized by ß-TrCP, thus allowing subsequent polyubiquitination and proteasome-mediated destruction of I
B (7)
. Genetic evidence obtained from mouse models and from NF-
B defects identified in humans demonstrates the importance of NF-
B for an effective mounting of the immune response (8)
. Therefore, hyperactivation of otherwise beneficial immune responses as seen in diseases such as asthma, arthritis, or autoimmunity may be combated by interference with NF-
B activity. This review focuses on signal transducing proteins relevant for NF-
B activation elicited by T cell costimulation, as schematically shown in Fig. 2
.
|
| EARLY SIGNALING EVENTS |
|---|
|
|
|---|
1, stimulation of mitogen-activated protein kinase (MAPK) pathways, and activation of Vav1. The inhibitory effect of the broad spectrum PTK inhibitor herbimycin A for TCR/CD28-induced NF-
B activation points to a role of early PTK activation (14)
B in response to engagement of TCR and CD28 (15)
B signaling cascade. | SMAC PROTEINS |
|---|
|
|
|---|
B activity after TCR/CD28 costimulation (15)
B was revealed by analysis of Vav1-/- mice, which fail to induce NF-
B activity after T cell costimulation (21)
B
degradation in Vav1-/- T cells, Vav1-mediated NF-
B activation seems to be independent from calcium signals (21)
B via induction of IKK activity and NF-
B DNA binding (22)
B activating function of Vav1 relies on its GEF activity, as expression of a Vav1 mutant lacking GEF activity fails to reconstitute NF-
B activation in a Vav1 null Jurkat cell line (23)
Another SMAC protein that recently revealed its identity as a member of the NF-
B activation cascade is PLC
1, which converts phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol (1
, 4
, 5)
-triphosphate (IP3) and diacylglycerol (DAG). While IP3 mobilizes Ca2+ from intracellular stores, DAG mediates activation of protein kinase C (PKC) family members (24)
. Prenatal mortality of PLC
1/ mice precludes analysis of this enzyme in a mouse model, but Jurkat cells deficient in PLC
1 expression fail to induce NF-
B activation in response to TCR/CD28 stimulation. Replenishment of PLC
1 expression restores costimulation-induced IKK activity as well as NF-
B DNA binding and trans-activation (16)
, thus identifying PLC
1 as an essential member of the TCR/CD28-triggered NF-
B activation pathway.
A mechanistic link between Vav1 and PLC
1 was recently established by analysis of double-positive thymocytes from Vav1-/- mice, which fail to phosphorylate and activate PLC
1 in response to T cell costimulation. This defect can be attributed to missing activation of the PTKs ITK and TEC and to a defective assembly of a signaling complex containing PLC
1 and SLP-76 (25)
. Accordingly, the activating tyrosine phosphorylation of PLC
1 is absent in SLP-76-negative Jurkat in response to T cell costimulation. Thus, Vav1 and SLP-76 are essential for TCR/CD28-induced PLC
1 activation in the NF-
B signaling cascade.
Another adaptor protein important for TCR-mediated NF-
B activation is SHC (SH2-containing sequence). It is a ZAP-70 substrate and inducibly associates with Grb2 after TCR stimulation (26)
. Expression of a mutated form of SHC blocks TCR-induced signal transduction, while targeting of SHC to lipid rafts results in enhanced TCR signaling (27)
. Jurkat T cells lacking SHC are unable to activate a NF-
B-dependent reporter gene and show no induced IL-2 transcription (28)
. Whereas the absence of SHC remains without effect on the induced nuclear translocation of p65, nuclear import of c-Rel is impaired. This finding provides an interesting opportunity to study differential gene expression between these two trans-activating members of the NF-
B transcription factor family. However, the precise mechanisms leading to the selective failure of c-Rel recruitment to the nucleus remain to be established.
PKC
|
|---|
|
|
|---|
B activation cascade in T cells. Mature T lymphocytes from PKC
-/- mice fail to induce I
B degradation after T cell costimulation, but NF-
B activation induced by IL-1 or TNF
remains unaffected (29)
, whereas T cell costimulation leads to the transient dissociation of the Vav1/PKC
complex (22)
, but not of any other PKC isoform, potently activates NF-
B in T cells (22
exerts its activating effects on NF-
B upon triggering of IKK activity, but it also stimulates the trans-activating function of NF-
B by physical and functional cooperation with Akt1 (protein kinase B) (32)
for NF-
B strictly relies on its kinase activity, but direct phosphorylation substrates on the road to NF-
B activation remain incompletely defined. After T cell stimulation, only PKC
, none of the other various PKC isoforms, is selectively transported to lipid rafts contained within the immunological synapse (33
is required for its NF-
B activating function (34)
The relative importance of PLC
1 and Vav1 for lipid raft recruitment of PKC
does not yield a coherent picture. Selective inhibition of PLC
1 enzymatic activity or expression of a dominant-negative PLC
1 mutant does not preclude PKC
raft recruitment (36)
. On the other hand, Jurkat cells lacking PLC
1 fail to translocate PKC
to the lipid raft fraction (16)
, suggesting that the importance of PLC
1 for PKC
raft recruitment can be attributed to its function as an adaptor protein rather than to its enzymatic function. Although PKC
transport to lipid rafts cannot be seen in T cells from Vav1-/- mice (37)
, a Vav1-deficient human Jurkat cell line generated by somatic gene targeting shows normal raft translocation (23)
. These differences may reflect species specificity or, alternatively, suggest that the recruitment pathways depend on the developmental stage of the T cell. Accordingly, PKC
is required only for NF-
B activation in mature T lymphocytes but not in thymocytes (29)
.
| PROTEIN KINASES |
|---|
|
|
|---|
B activation pathway. One of these is calmodulin-dependent kinase II (CaMKII). Overexpression of a constitutively active form of this Ca2+-dependent kinase leads to NF-
B activation in T cells. A CaMKII inhibitor prevents degradation of I
B
induced by TCR- or the phorbol ester PMA (38)
B by TNF
is not affected in the presence of this inhibitor, pointing to a pathway-specific role of CaMKII. In addition, I
B degradation by the pleiotropic PKC activator PMA does not occur in the presence of a CaMKII inhibitor, suggesting CaMKII acts downstream from PKC
.
In T cells, two MAPKKKs have been shown to be important for T cell costimulation-induced NF-
B activity: mixed lineage kinase-3 (MLK3) and the proto-oncogene COT/Tpl-2. Expression of the wild-type form of MLK3 induces nuclear immigration and DNA binding of NF-
B, whereas MLK3-induced transcriptional activity of NF-
B is relatively weak (39)
. MLK3 directly binds and phosphorylates both IKKs. A kinase-deficient version of MLK3 impairs only NF-
B-dependent transcription induced by T cell costimulation, but not NF-
B activity elicited by TNF
or IL-1. Accordingly, endogenous MLK3 is phosphorylated only after T cell costimulation but not by treatment with TNF
or IL-1. In support of a signal-specific role for MLK3 in T cells, the Tax protein encoded by the human T lymphotropic virus type 1 up-regulates MLK3 levels and activates NF-
B (40)
. The TCR/CD28-mediated MLK3 activation pathway is mediated by Rho family GTPases RAC and CDC42 (39
, 41)
.
The second MAP3K involved in TCR/CD28-induced activation of NF-
B is COT. Overexpression of COT triggers transcription from a NF-
B-dependent reporter gene and stimulates endogenous IKK activity (42)
. A dominant-negative form of COT prevents only TCR/CD28- but not TNF
-mediated activation of NF-
B. COT physically assembles with NIK and IKK
in vivo, but the pathway triggered by COT is distinct from that activated by MLK3 since COT leads to the activation of NIK. COT can be activated by AKT, which binds to COT and phosphorylates serine 400 near the carboxyl terminus of COT. Mutation of this serine in COT creates a dominant-negative form of COT that selectively prevents TCR/CD28-induced NF-
B activation while not affecting TNF
-derived signals (43)
. Besides its stimulatory effect on COT, the AKT kinase also enhances NF-
B-dependent trans-activation triggered by PKC
(32)
. It will be interesting to see whether mice lacking COT (44)
or MLK3 have any defects in NF-
B activation triggered by T cell costimulation. A role for NIK was revealed by analysis of T cells from aly mice, a strain with mutant NIK. TCR stimulation resulted in an impaired NF-
B DNA binding in mature and immature T cells, while responses to costimulatory signals were not significantly changed (45)
.
Evidence for the involvement of RICK/RIP2/CARDIAK was obtained from an analysis of mice lacking this serine/threonine kinase. T cells from Rip2-/- animals show strongly impaired phosphorylation of I
B
and NF-
B DNA binding after TCR engagement (46)
. Since RIP2 is important for signals transmitted via Toll-like receptors 2 and 4, this kinase operates in several pathways. T cells also contain IKK
, another member of the IKK family. IKK
(termed IKKi) displays
30% sequence identity to IKK
/ß. IKK
activity can be induced upon TCR stimulation but not by IL-1 or TNF
(47)
, suggesting that this kinase may be important in the process of TCR-derived NF-
B activation. IKK
phosphorylates serine 36 of I
B
, but it remains to be seen whether I
B
is the main physiologically important substrate for this kinase. IKK
is closely related to the IKK homologous kinase TBK1/NAK. Knockout experiments show that TBK1/NAK is dispensable for induced phosphorylation of I
B
; rather, it contributes to NF-
B-mediated trans-activation. Therefore, it will be interesting to study the effect of targeted disruption of IKK
for NF-
B trans-activation in T lymphocytes.
| ACTIVATION OF THE IKK COMPLEX |
|---|
|
|
|---|
/NEMO to the TCR
chain, causing inducible translocation of the IKK complex to the immunological synapse (48)
/NEMO to the membrane is sufficient to induce constitutive NF-
B activation (48)
) or by auto- and transphosphorylation of the IKKs themselves (49
B activation induced by transient overexpression of wild-type Bcl10 in cell lines is dependent on its amino-terminal CARD (52)
B in response to T cell costimulation (53)
B activation. Since these agents bypass the early signaling steps and directly elevate Ca2+ fluxes and PKC activity, this finding indicates that Bcl10 is located at the level of or downstream from PKC
. Accordingly, early tyrosine phosphorylation, mobilization of Ca2+, and activation of JNK/AP-1 are normal in Bcl10/cells (53)
B in the absence of any intrinsic enzymatic activity? A possible clue comes from the finding that its viral homologue vCLAP/E10 from equine herpes virus persistently activates NF-
B through direct binding and oligomerization of IKK
(54)
strongly activates NF-
B (55)
B activating function of Bcl10. Accordingly, Bcl10-mediated NF-
B activation requires the arrangement of Bcl10 in cytoplasmic filaments (56)
B activation pathway.
Bcl10 is found in association with several other proteins, including MALT1. Similar to Bcl10, the gene encoding MALT1 is affected by a chromosomal translocation involved in the same type of MALT lymphoma. MALT1 is composed of a death domain, two immunoglobulin-like domains, and a carboxyl-terminal caspase-like domain and cooperates with Bcl10 for the induction of NF-
B (57)
. Bcl10 also binds to the membrane-associated guanylate kinase (MAGUK) proteins CARD10 (58)
, CARD14 (59)
, and CARD11/CARMA1 (59
, 60)
. The importance of CARMA1 for the activation of NF-
B was revealed in several studies. Elimination of CARMA1 expression by either somatic mutagenesis or expression of small interfering RNAs prevents NF-
B activation triggered by TCR/CD28 cross-linking (61
, 62)
. Accordingly, a CARMA1 mutant incapable of binding to Bcl10 acts as a dominant-negative mutant and prevents TCR/CD28-stimulated NF-
B activation and IL-2 production (63)
. It seems that CARMA1 serves to link PKC
-derived signals to Bcl10, as overexpression of a constitutively active form of PKC
fails to induce NF-
B in CARMA1-deficient Jurkat T cells but not in control cells retransfected to express CARMA1 (61)
. A dominant-negative CARMA1 mutant also interferes with PMA/ionomycin-induced NF-
B activation, showing that this MAGUK family member acts downstream from PKC
. On the other hand, there is increasing evidence that CARMA1 functions upstream from Bcl10. Overexpression of CARMA1 stimulates the phosphorylation of Bcl10 (60)
, but neither the exact phosphorylation sites nor the kinases involved are known to date. CARMA1 is constitutively associated with lipid rafts, whereas cytoplasmic Bcl10 translocates into lipid rafts only upon TCR engagement (63)
. Overexpression of CARMA1 recruits Bcl10 to the cytoplasmic membrane (61)
; association of both proteins is observed only in stimulated T cells (63)
, suggesting that CARMA1 assists in lipid raft recruitment of Bcl10. The use of genetic models in combination with new tools in biochemistry (e.g., tandem affinity purification technology, which allows the identification of inducible protein/protein interactions), molecular biology (e.g., knockdown by RNA interference), and cell biology (visualization of protein migration in living cells using fusions to the green fluorescent protein) will open new doors to the identification of further NF-
B regulators in T lymphocytes. Since the global inhibition of this transcription factor might result in serious side effects, this information will be valuable for the development of T cell-specific immunosuppressive NF-
B inhibitors.
| FOOTNOTES |
|---|
Received for publication March 27, 2003. Accepted for publication August 5, 2003.
| REFERENCES |
|---|
|
|
|---|
B activity. Annu. Rev. Immunol. 18,621-663[CrossRef][Medline]
in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157,253-263This article has been cited by other articles:
![]() |
M. Humar, H. Dohrmann, P. Stein, N. Andriopoulos, U. Goebel, M. Roesslein, R. Schmidt, C. I. Schwer, T. Loop, K. K. Geiger, et al. Thionamides Inhibit the Transcription Factor Nuclear Factor-{kappa}B by Suppression of Rac1 and Inhibitor of {kappa}B Kinase {alpha} J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1037 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Moynagh The NF-{kappa}B pathway J. Cell Sci., October 15, 2005; 118(20): 4589 - 4592. [Full Text] [PDF] |
||||
![]() |
F. H. Sarkar and Y. Li Indole-3-Carbinol and Prostate Cancer J. Nutr., December 1, 2004; 134(12): 3493S - 3498S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Fan, L. H. Ly, R. Barhoumi, D. N. McMurray, and R. S. Chapkin Dietary Docosahexaenoic Acid Suppresses T Cell Protein Kinase C{theta} Lipid Raft Recruitment and IL-2 Production J. Immunol., November 15, 2004; 173(10): 6151 - 6160. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang and R. L. Wange T Cell Receptor Signaling: Beyond Complex Complexes J. Biol. Chem., July 9, 2004; 279(28): 28827 - 28830. [Full Text] [PDF] |
||||
![]() |
I. Mattioli, A. Sebald, C. Bucher, R.-P. Charles, H. Nakano, T. Doi, M. Kracht, and M. L. Schmitz Transient and Selective NF-{kappa}B p65 Serine 536 Phosphorylation Induced by T Cell Costimulation Is Mediated by I{kappa}B Kinase {beta} and Controls the Kinetics of p65 Nuclear Import J. Immunol., May 15, 2004; 172(10): 6336 - 6344. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |